Conference Call and Webcast Today, May 7, 2015 at 4:30 p.m. Eastern Time ANN ARBOR, MI–(Marketwired – May 07, 2015) – Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company […]
SAN DIEGO–(BUSINESS WIRE)–La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Biogen (NASDAQ:BIIB) today announced that its Board of Directors has authorized a program to repurchase up to $5 billion of the Company’s common stock. The share repurchase program […]
DALLAS, TX and CLEVELAND, OH and NEW YORK, NY–(Marketwired – May 06, 2015) – Company is well positioned to execute on its strategy to become a leader in cell therapy […]
In his 25-year-tenure at Gilead, first as research chief and then as the boss, Martin led the development of the most widely prescribed HIV pill and, last year, a treatment […]
RESEARCH TRIANGLE PARK, NC–(Marketwired – May 05, 2015) – Medical device manufacturers face increasing competition as they move products through development and into a saturated market. According to a new report […]
MIAMI–(BUSINESS WIRE)–OPKO Health, Inc. (NYSE:OPK) is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and […]
“Reputation, built on our past, shapes our present and future. A good reputation can open many doors; a bad reputation can close many more. A good reputation generates respect. A […]
MOUNTAIN VIEW, CA–(Marketwired – May 05, 2015) – VIVUS, Inc. (NASDAQ: VVUS) (the “Company”), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, […]
Antisense Approach for Clotting Disorders Whippany, NJ – WEBWIRE – Monday, May 04, 2015 Bayer HealthCare (Bayer) has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) […]
